摘要
目的:分析阿司匹林、氯吡格雷在抗血小板聚集治疗中的ADR及影响ADR结果的危险因素,为临床用药提供参考。方法:以2009-2012年上海ADR中心数据库阿司匹林和氯吡格雷病例为基数,通过年龄或单抗和双抗治疗随机分组进行回顾性分析,以报告类型、严重程度、原患疾病、用药原因、ADR致器官损害、ADR起始发病日、ADR结果作为观察指标,使用SPSS软件进行分析。结果:单抗和双抗两组基线特征比较差异无统计学意义(p>0.05)。两组观察指标相关性检查及单因素独立危险因素比较,严重程度、出血、ADR结果和ADR最初阶段发病p<0.05;多因素Logistic回归分析,ADR未好转OR = 3.404、95% CI 1.518~7.634;ADR周内发病OR = 3.329、95% CI 0.86~12.884。结论:双抗组的缺血、出血事件几率高于单抗组,单抗组未好转几率是双抗组的2.44倍,可能与抗血小板药物抵抗、合并用药的相互作用及剂量不足有关。长期抗血小板治疗应综合评估患者缺血、出血风险,制定个体化的预防措施和给药方法,在抗血小板效果与降低出血风险之间以取得平衡和最大获益。
Objective:To analyze the adverse drug reaction and their risk factors of Aspirin and Clopidogrelduring the treatment for platelet aggregation, providing reference for clinicalmedication. Methods: Based on 2009-2012 database of Shanghai ADRs center, ADRcases about Aspirin and Clopidogrel were analyzed retrospectively through agegroups or randomized by combination and independence for retrospectiveanalysis. Also the types of reports, severity of diseases, the originaldisease, the reason of medication, organ damage by ADR, as well as the initialperiod and results of ADRs were applied as the observation indexes and wereanalyzed by using the SPSS software. Results: In the groups of combination andindependence, their p value of baseline characteristics was above 0.05 (p >0.05), which indicated nostatistical significance. In contrast, p values of observation indexcorrelation test, report types, severity, bleeding part, ADR results and theinitial period of ADR were below the level of 0.05.
出处
《医学诊断》
2015年第3期29-35,共7页
Medical Diagnosis
基金
上海市食品药品监督管理局科技情报研究所委托课题(药品不良反应临床研究——聚焦抗凝药GJ1206)。